These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19268068)

  • 1. Cardiovascular morbidity and mortality and left ventricular geometric patterns in hypertensive patients treated in primary care.
    Tovillas-Morán FJ; Zabaleta-del-Olmo E; Dalfó-Baqué A; Vilaplana-Cosculluela M; Galcerán JM; Coca A
    Rev Esp Cardiol; 2009 Mar; 62(3):246-54. PubMed ID: 19268068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study.
    Li T; Li G; Guo X; Li Z; Sun Y
    BMC Cardiovasc Disord; 2021 May; 21(1):238. PubMed ID: 33980151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular morbidity and mortality and electrocardiographic criteria of left ventricular hypertrophy in hypertensive patients treated in primary care].
    Tovillas-Morán FJ; Vilaplana-Cosculluela M; Zabaleta-del-Olmo E; Dalfó-Baqué A; Galcerán JM; Coca A
    Med Clin (Barc); 2010 Sep; 135(9):397-401. PubMed ID: 20816389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease.
    Saito M; Khan F; Stoklosa T; Iannaccone A; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):911-21. PubMed ID: 27344417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Santucci A; Santucci C; Reboldi G; Porcellati C
    Am J Cardiol; 1996 Jul; 78(2):197-202. PubMed ID: 8712142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension.
    Takasaki K; Miyata M; Imamura M; Yuasa T; Kuwahara E; Kubota K; Kono M; Ueya N; Horizoe Y; Chaen H; Mizukami N; Kisanuki A; Hamasaki S; Tei C
    Circ J; 2012; 76(6):1409-14. PubMed ID: 22447013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study].
    Li Y; Zhao D; Liu J; Li CF; Guo W; Chen CH; Hao P; Sun JY; Qin LP; Wang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1037-42. PubMed ID: 19102921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Tei Index and left ventricular geometric patterns in a hypertensive population: a cross-sectional study.
    Karaye KM
    Cardiovasc Ultrasound; 2011 Jul; 9():21. PubMed ID: 21794182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function.
    Lavie CJ; Milani RV; Patel D; Artham SM; Ventura HO
    Postgrad Med; 2009 May; 121(3):119-25. PubMed ID: 19491549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
    Taylor HA; Penman AD; Han H; Dele-Michael A; Skelton TN; Fox ER; Benjamin EJ; Arnett DK; Mosley TH
    Am J Cardiol; 2007 May; 99(10):1413-20. PubMed ID: 17493471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study).
    Toprak A; Wang H; Chen W; Paul T; Srinivasan S; Berenson G
    Am J Cardiol; 2008 Jun; 101(11):1621-5. PubMed ID: 18489940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
    Gerdts E; Cramariuc D; de Simone G; Wachtell K; Dahlöf B; Devereux RB
    Eur J Echocardiogr; 2008 Nov; 9(6):809-15. PubMed ID: 18490279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-treatment stroke volume predicts cardiovascular risk in hypertension.
    Lønnebakken MT; Gerdts E; Boman K; Wachtell K; Dahlöf B; Devereux RB
    J Hypertens; 2011 Aug; 29(8):1508-14. PubMed ID: 21720264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.